Graduate Program Collective Health, University of Brasilia, Brasilia, District federal, Brazil.
PLoS One. 2021 Oct 21;16(10):e0258488. doi: 10.1371/journal.pone.0258488. eCollection 2021.
Neural tube defects (NTDs) constitute the most frequent group among congenital malformations and are the main cause of neonatal morbimortality. Folic acid (FA) can reduce the risk of pregnancies affected by NTDs.
We aimed to investigate whether mandatory folic acid (FA) fortification of flours is cost-effective as compared to non-mandatory fortification, and to verify whether FA dosage, cost composition, and the quality of economic studies influence the cost-effectiveness of outcomes.
We conducted a systematic review. The protocol was registered on PROSPERO (CRD 42018115682). A search was conducted using the electronic databases MEDLINE/PubMed, Web of Science, Embase, Scopus, and EBSCO/CINAHL between January 2019 and October 2020 and updated in February 2021. Eligible studies comprised original economic analyses of mandatory FA fortification of wheat and corn flours (maize flours) compared to strategies of non-mandatory fortification in flours and/or use of FA supplements for NTD prevention. The Drummond verification list was used for quality analysis.
A total of 7,859 studies were identified, of which 13 were selected. Most (77%; n = 10) studies originated from high-income countries, while three (23%) were from upper-middle-income countries. Results of a cost-effectiveness analysis showed that fortification is cost-effective for NTD prevention, except for in one study in New Zealand. The cost-benefit analysis yielded a median ratio of 17.5:1 (0.98:1 to 417.1:1), meaning that for each monetary unit spent in the program, there would be a return of 17.5 monetary units. Even in the most unfavorable case of mandatory fortification, the investment in the program would virtually payoff at a ratio of 1:0.98. All FA dosages were cost-effective and offered positive health gains, except in one study. The outcomes of two studies showed that FA dosages above 300 μg/100 g have a higher CBA ratio. The studies with the inclusion of "loss of consumer choice" in the analysis may alter the fortification cost-efficacy ratio.
We expect the findings to be useful for public agencies in different countries in decision-making on the implementation and/or continuity of FA fortification as a public policy in NTD prevention.
神经管缺陷(NTDs)构成了先天性畸形中最常见的一组,也是新生儿发病率和死亡率的主要原因。叶酸(FA)可以降低受 NTDs 影响的妊娠风险。
我们旨在研究与非强制性强化相比,强制性面粉强化叶酸(FA)是否具有成本效益,并验证 FA 剂量、成本构成以及经济研究的质量是否会影响结果的成本效益。
我们进行了系统评价。该方案在 PROSPERO(CRD42018115682)上进行了注册。使用电子数据库 MEDLINE/PubMed、Web of Science、Embase、Scopus 和 EBSCO/CINAHL 于 2019 年 1 月至 2020 年 10 月进行了检索,并于 2021 年 2 月进行了更新。合格的研究包括对小麦和玉米(玉米)粉进行强制性 FA 强化与非强制性强化策略在面粉中的比较,以及 FA 补充剂用于 NTD 预防的原始经济分析。使用 Drummond 验证清单进行质量分析。
共确定了 7859 项研究,其中有 13 项被选中。大多数(77%;n=10)研究来自高收入国家,而三项(23%)来自中上收入国家。成本效益分析的结果表明,强化对于 NTD 预防是具有成本效益的,新西兰的一项研究除外。成本效益分析产生了中位数比率为 17.5:1(0.98:1 至 417.1:1),这意味着每在该计划中花费一单位货币,就会有 17.5 个单位货币的回报。即使在最不利的强制性强化情况下,该计划的投资实际上也将以 1:0.98 的比例获得回报。所有 FA 剂量均具有成本效益并带来了积极的健康收益,除了一项研究之外。两项研究的结果表明,FA 剂量超过 300μg/100g 会有更高的 CBA 比率。在分析中包含“消费者选择的损失”的研究可能会改变强化的成本效益比。
我们预计这些发现将有助于不同国家的公共机构在实施和/或继续作为 NTD 预防公共政策的叶酸强化方面做出决策。